Imugene tweeted about Dr Bilal Shah delivering an encore presentation at the iwCAR-T 2024 meeting in Florida, on 'Updates for Allo CAR-T PBCAR0191: Bijal Shah'.
What is also interesting is that 2 members of our Scientific Advosry Board also presented at this conference. So Imugene definitely has some firepower in the CAR-T space.
Under CAR-T advances in Lung cancer:
- Tumor immune modulation in solid tumor CAR T-cell therapy: Prasad Adusumilli.
Under Genitourinary cancers.
- Advancing engineered T-cell therapies for solid tumors: Saul Priceman
GLTAH
Imugene tweeted about Dr Bilal Shah delivering an encore...
-
- There are more pages in this discussion • 3,715 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 4.8¢ | 4.9¢ | 4.8¢ | $573.9K | 11.93M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 41 | 6251688 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 3022777 | 8 |
View Market Depth
| Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |